OPKO Health Inc. (OPK) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OPKO Health Inc. (OPK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.47

-0.06 (-3.92%)

At close: Jan 14, 2025, 3:59 PM

1.49

1.71%

Pre-market Jan 15, 2025, 06:01 AM EST

undefined% (undefined)

Bid	1.49
Market Cap	999.84M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.19
PE Ratio (ttm)	-7.71
Forward PE	n/a
Analyst	Buy

Ask	1.5
Volume	3,062,012
Avg. Volume (20D)	3,996,703
Open	1.53
Previous Close	1.53
Day's Range	1.44 - 1.54
52-Week Range	0.86 - 1.76
Beta	undefined

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, geneti...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Nov 2, 1995

Employees 3,930

Stock Exchange NASDAQ

Ticker Symbol OPK

Website https://www.opko.com

Analyst Forecast

According to 3 analyst ratings, the average rating for OPK stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 104.78% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

OPKO Health Inc. is scheduled to release its earnings on Feb 25, 2025, during market hours.
Analysts project revenue of $167.82M, reflecting a -7.74% YoY shrinking and earnings per share of -0.08, making a -11.11% decrease YoY.

Why Price Moved

1 week ago · Source

+4.14%

Merck & Compnay and OPKO Health shares are trading... Unlock content with Pro Subscription

5 months ago · Source

+11.72%

OPKO Health shares are trading higher after the company reported better-than-expected Q2 EPS results.

News

6 days ago · zacks.com

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

OPK's growth is fueled by Rayaldee's success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.

1 week ago · zacks.com

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.

2 weeks ago · marketbeat.com

3 Stocks That Wall Street Insiders Can't Stop Buying

Insider activity is hot in names like Vestis NYSE: VSTS, OPKO Health NASDAQ: OPK, and Greif, Inc. NYSE: GEF, and investors should take notice. From board members to CEOs, CFOs, and other corporate off...

2 months ago · zacks.com

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Lower revenues from OPKO Health's products and services dampen its overall third-quarter 2024 performance.

2 months ago · zacks.com

Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 Earnings

Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall ...

2 months ago · seekingalpha.com

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

OPKO Health, Inc. (NASDAQ:OPK ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Yvonne Briggs - Alliance Advisor, IR Phillip Frost - Chairman and CEO Elias Zerhouni -...

2 months ago · zacks.com

OPKO Health (OPK) Q3 Earnings Surpass Estimates

OPKO Health (OPK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to loss of $0.11 per share a year ago.